118 related articles for article (PubMed ID: 2164806)
1. Effect of genistein, a tyrosine kinase inhibitor, on U46619-induced phosphoinositide phosphorylation in human platelets.
Gaudette DC; Holub BJ
Biochem Biophys Res Commun; 1990 Jul; 170(1):238-42. PubMed ID: 2164806
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
4. Effect of albumin-bound DHA on phosphoinositide phosphorylation in collagen stimulated human platelets.
Gaudette DC; Holub BJ
Thromb Res; 1990 May; 58(4):435-44. PubMed ID: 2162088
[TBL] [Abstract][Full Text] [Related]
5. BW755C or staurosporine inhibits collagen-stimulated phosphoinositide phosphorylation in platelets.
Thomas LM; Holub BJ
Lipids; 1991 Sep; 26(9):689-95. PubMed ID: 1662328
[TBL] [Abstract][Full Text] [Related]
6. Effects of genistein, a tyrosine kinase inhibitor, on platelet functions. Genistein attenuates thrombin-induced Ca2+ mobilization in human platelets by affecting polyphosphoinositide turnover.
Ozaki Y; Yatomi Y; Jinnai Y; Kume S
Biochem Pharmacol; 1993 Aug; 46(3):395-403. PubMed ID: 8394081
[TBL] [Abstract][Full Text] [Related]
7. The effects of genistein on platelet function are due to thromboxane receptor antagonism rather than inhibition of tyrosine kinase.
McNicol A
Prostaglandins Leukot Essent Fatty Acids; 1993 May; 48(5):379-84. PubMed ID: 8321874
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
Dhar A; Paul AK; Shukla SD
Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
[TBL] [Abstract][Full Text] [Related]
9. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses.
Nakashima S; Koike T; Nozawa Y
Mol Pharmacol; 1991 Apr; 39(4):475-80. PubMed ID: 2017148
[TBL] [Abstract][Full Text] [Related]
10. Specific attenuation of the pressure-induced contraction of rat cerebral artery by herbimycin A.
Masumoto N; Nakayama K; Oyabe A; Uchino M; Ishii K; Obara K; Tanabe Y
Eur J Pharmacol; 1997 Jul; 330(1):55-63. PubMed ID: 9228414
[TBL] [Abstract][Full Text] [Related]
11. Mass and fatty acid composition of the 3-phosphorylated phosphatidylinositol bisphosphate isomer in stimulated human platelets.
Gaudette DC; Aukema HM; Jolly CA; Chapkin RS; Holub BJ
J Biol Chem; 1993 Jul; 268(19):13773-6. PubMed ID: 8390977
[TBL] [Abstract][Full Text] [Related]
12. Role of tyrosine phosphorylation in U46619-induced vasoconstriction of pulmonary vasculature and its modulation by genistein, daidzein, and equol.
Liu C; Tazzeo T; Lippton H; Janssen LJ
J Cardiovasc Pharmacol; 2007 Oct; 50(4):441-8. PubMed ID: 18049313
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
14. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
15. Involvement of phospholipase C-gamma2 in activation of mitogen-activated protein kinase and phospholipase A2 by zooxanthellatoxin-A in rabbit platelets.
Rho MC; Nakahata N; Nakamura H; Murai A; Ohizumi Y
J Pharmacol Exp Ther; 1997 Jul; 282(1):496-504. PubMed ID: 9223592
[TBL] [Abstract][Full Text] [Related]
16. Fc gamma receptor II stimulated formation of inositol phosphates in human platelets is blocked by tyrosine kinase inhibitors and associated with tyrosine phosphorylation of the receptor.
Blake RA; Asselin J; Walker T; Watson SP
FEBS Lett; 1994 Mar; 342(1):15-8. PubMed ID: 8143842
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein.
Asahi M; Yanagi S; Ohta S; Inazu T; Sakai K; Takeuchi F; Taniguchi T; Yamamura H
FEBS Lett; 1992 Aug; 309(1):10-4. PubMed ID: 1511739
[TBL] [Abstract][Full Text] [Related]
18. ADP- and thapsigargin-evoked Ca2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in fura-2-loaded human platelets.
Sargeant P; Farndale RW; Sage SO
J Biol Chem; 1993 Aug; 268(24):18151-6. PubMed ID: 7688740
[TBL] [Abstract][Full Text] [Related]
19. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
20. Comparison of maitotoxin with thromboxane A2 in rabbit platelet activation.
Nakahata N; Ohkubo S; Ito E; Nakano M; Terao K; Ohizumi Y
Toxicon; 1999 Oct; 37(10):1375-89. PubMed ID: 10414863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
